175 related articles for article (PubMed ID: 21881977)
41. Effects of connexin-mimetic peptides on nitric oxide synthase- and cyclooxygenase-independent renal vasodilation.
De Vriese AS; Van de Voorde J; Lameire NH
Kidney Int; 2002 Jan; 61(1):177-85. PubMed ID: 11786099
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of nitric oxide synthase by L-NAME improves ventricular performance in streptozotocin-diabetic rats.
Smith JM; Paulson DJ; Romano FD
J Mol Cell Cardiol; 1997 Sep; 29(9):2393-402. PubMed ID: 9299363
[TBL] [Abstract][Full Text] [Related]
43. Relationship between basal NO release and cyclooxygenase products in the normal rat kidney.
Baylis C; Slangen B; Hussain S; Weaver C
Am J Physiol; 1996 Nov; 271(5 Pt 2):R1327-34. PubMed ID: 8945971
[TBL] [Abstract][Full Text] [Related]
44. ET(B) receptor and nitric oxide synthase blockade induce BQ-123-sensitive pressor effects in the rabbit.
Gratton JP; Cournoyer G; Löffler BM; Sirois P; D'Orléans-Juste P
Hypertension; 1997 Nov; 30(5):1204-9. PubMed ID: 9369277
[TBL] [Abstract][Full Text] [Related]
45. Differential release of prostacyclin and nitric oxide evoked from pulmonary and systemic vascular beds of the pig by endothelin-1.
Clement MG; Albertini M
Prostaglandins Leukot Essent Fatty Acids; 1996 Oct; 55(4):279-85. PubMed ID: 8951997
[TBL] [Abstract][Full Text] [Related]
46. Endothelin-3 regulation of retinal hemodynamics in nondiabetic and diabetic rats.
Mori F; King GL; Clermont AC; Bursell DK; Bursell SE
Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3955-62. PubMed ID: 11053299
[TBL] [Abstract][Full Text] [Related]
47. Coronary vasoconstriction to endothelin-1 increases with age before and after ischaemia and reperfusion.
Goodwin AT; Amrani M; Marchbank AJ; Gray CC; Jayakumar J; Yacoub MH
Cardiovasc Res; 1999 Mar; 41(3):554-62. PubMed ID: 10435027
[TBL] [Abstract][Full Text] [Related]
48. Interactive modulation of renal myogenic autoregulation by nitric oxide and endothelin acting through ET-B receptors.
Shi Y; Lau C; Cupples WA
Am J Physiol Regul Integr Comp Physiol; 2007 Jan; 292(1):R354-61. PubMed ID: 16990488
[TBL] [Abstract][Full Text] [Related]
49. Acute hypertension after nitric oxide synthase inhibition is mediated primarily by increased endothelin vasoconstriction.
Banting JD; Friberg P; Adams MA
J Hypertens; 1996 Aug; 14(8):975-81. PubMed ID: 8884552
[TBL] [Abstract][Full Text] [Related]
50. Long-term nitric oxide synthase inhibition prevents 17β-estradiol-induced suppression of cyclooxygenase-dependent contractions and enhancement of endothelium-dependent hyperpolarization-like relaxation in mesenteric arteries of ovariectomized rats.
Shi Y; Leung SWS
Eur J Pharmacol; 2020 Sep; 882():173275. PubMed ID: 32535100
[TBL] [Abstract][Full Text] [Related]
51. The effects of endothelin-1 and NG-nitro-L-arginine methyl ester on regional haemodynamics in conscious rats with streptozotocin-induced diabetes mellitus.
Kiff RJ; Gardiner SM; Compton AM; Bennett T
Br J Pharmacol; 1991 Jun; 103(2):1321-6. PubMed ID: 1884094
[TBL] [Abstract][Full Text] [Related]
52. Inhibition of neuronal nitric oxide synthase ameliorates renal hyperfiltration in streptozotocin-induced diabetic rat.
Ito A; Uriu K; Inada Y; Qie YL; Takagi I; Ikeda M; Hashimoto O; Suzuka K; Eto S; Tanaka Y; Kaizu K
J Lab Clin Med; 2001 Sep; 138(3):177-85. PubMed ID: 11528370
[TBL] [Abstract][Full Text] [Related]
53. Effects of combined neutral endopeptidase 24-11 and angiotensin-converting enzyme inhibition on femoral vascular conductance in streptozotocin-induced diabetic rats.
Arbin V; Claperon N; Fournié-Zaluski MC; Roques BP; Peyroux J
Br J Pharmacol; 2000 Jul; 130(6):1297-304. PubMed ID: 10903969
[TBL] [Abstract][Full Text] [Related]
54. Calcitonin gene-related peptide reduces renal vascular resistance and modulates ET-1-induced vasoconstriction.
Amuchastegui CS; Remuzzi G; Perico N
Am J Physiol; 1994 Nov; 267(5 Pt 2):F839-44. PubMed ID: 7977788
[TBL] [Abstract][Full Text] [Related]
55. Regional heterogeneity in the haemodynamic responses to urotensin II infusion in relation to UT receptor localisation.
Gardiner SM; March JE; Kemp PA; Maguire JJ; Kuc RE; Davenport AP; Bennett T
Br J Pharmacol; 2006 Mar; 147(6):612-21. PubMed ID: 16314853
[TBL] [Abstract][Full Text] [Related]
56. Contribution of endogenous endothelin-1 to the maintenance of vascular tone: role of nitric oxide.
Gellai M; De Wolf R; Fletcher T; Nambi P
Pharmacology; 1997 Dec; 55(6):299-308. PubMed ID: 9413859
[TBL] [Abstract][Full Text] [Related]
57. Modulation of vascular reactivity in normal, hypertensive and diabetic rat aortae by a non-antioxidant flavonoid.
Ajay M; Achike FI; Mustafa MR
Pharmacol Res; 2007 May; 55(5):385-91. PubMed ID: 17317209
[TBL] [Abstract][Full Text] [Related]
58. Increased gastric bicarbonate secretion in portal hypertensive anesthetized rats: role of prostaglandins and nitric oxide.
Lamarque D; Dutreuil C; Dhumeaux D; Delchier JC
Dig Dis Sci; 1997 Apr; 42(4):743-50. PubMed ID: 9125643
[TBL] [Abstract][Full Text] [Related]
59. Impaired coronary sensitivity to diltiazem in experimental heart failure: involvement of the cyclooxygenase but not the nitric oxide-synthase pathway.
Tanguay M; Jasmin G; Blaise G; Dumont L
J Cardiovasc Pharmacol; 1996 Aug; 28(2):232-9. PubMed ID: 8856478
[TBL] [Abstract][Full Text] [Related]
60. Oxidative stress induced by tert-butyl hydroperoxide causes vasoconstriction in the aorta from hypertensive and aged rats: role of cyclooxygenase-2 isoform.
Garcia-Cohen EC; Marin J; Diez-Picazo LD; Baena AB; Salaices M; Rodriguez-Martinez MA
J Pharmacol Exp Ther; 2000 Apr; 293(1):75-81. PubMed ID: 10734155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
